14th Tumour Models Summit London 2025, December 3-4, 2025

Conference

genOway presentation

Event
-
December 3, 2025

genOway's presentation:

🕒 Wednesday, December 3, 2025 | 3.30 p.m. GMT

🎤 Fabiane Sônego, Director - Preclinical Models & Services

Advancing translational immuno-oncology: tumor–immune dynamics and predictive humanized models for immunotherapies

  • Highlighting the recruitment dynamics of human immune subsets within the tumor microenvironment in humanized mice
  • Harnessing the role of human myeloid and lymphoid cells to investigate tumor biology and therapeutic efficacy
  • Showcasing the critical role of myeloid cells in therapy-related immune-related adverse events (IrAEs)

14th Tumour Models Summit London 2025, December 3-4, 2025

Get in touch

Let us know how we can help

Other news & events

14th Tumour Models Summit London 2025, December 3-4, 2025
Conference
genOway presentation
Event
-
Dec 2025
Read on
genOway Shanghai at the 16th China International Pharmaceutical Expo 2025
Conference
Event
-
Nov 2025
Read on
7th Myeloid-Directed Summit 2025, November 18-20, 2025
Conference
genOway presentation
Event
-
Nov 2025
Read on
40th SITC meeting 2025, National Harbor, MD, November 5-9
Conference
genOway presentation
Event
-
Nov 2025
Read on
genOway Shanghai at BIONNOVA Beijing Forum 2025
Conference
Event
-
Sep 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe